MedPath

ORION PHARMA (AUS) PTY LIMITED

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

19

TGA:19

Drug Approvals

ANKSILON buspirone hydrochloride 5 mg tablet blister pack (422891)

Product Name
ANKSILON buspirone hydrochloride 5 mg tablet blister pack
Approval Date
Jan 16, 2025
TGA

ANKSILON buspirone hydrochloride 10 mg tablet blister pack (422890)

Product Name
ANKSILON buspirone hydrochloride 10 mg tablet blister pack
Approval Date
Jan 16, 2025
TGA

ORIDOPA 100/25 levodopa 100 mg/carbidopa (as monohydrate) 25 mg tablet bottle (427013)

Product Name
ORIDOPA 100/25 levodopa 100 mg/carbidopa (as monohydrate) 25 mg tablet bottle
Approval Date
Sep 16, 2024
TGA

DEXDOR dexmedetomidine (as hydrochloride) 1000 micrograms/10 mL concentrated injection vial (379410)

Product Name
DEXDOR dexmedetomidine (as hydrochloride) 1000 micrograms/10 mL concentrated injection vial
Approval Date
Nov 14, 2022
TGA

DEXDOR dexmedetomidine (as hydrochloride) 400 micrograms/4 mL concentrated injection vial (379411)

Product Name
DEXDOR dexmedetomidine (as hydrochloride) 400 micrograms/4 mL concentrated injection vial
Approval Date
Nov 14, 2022
TGA

DEXDOR dexmedetomidine (as hydrochloride) 200 micrograms/2 mL concentrated injection ampoule (379412)

Product Name
DEXDOR dexmedetomidine (as hydrochloride) 200 micrograms/2 mL concentrated injection ampoule
Approval Date
Nov 14, 2022
TGA

CHEXATE methotrexate (as sodium) 10 mg tablet blister pack (380990)

Product Name
CHEXATE methotrexate (as sodium) 10 mg tablet blister pack
Approval Date
Nov 14, 2022
TGA

CHEXATE methotrexate (as sodium) 2.5 mg tablet blister pack (380991)

Product Name
CHEXATE methotrexate (as sodium) 2.5 mg tablet blister pack
Approval Date
Nov 14, 2022
TGA

SALFLUMIX EASYHALER 500/50 fluticasone propionate/salmeterol (as xinafoate) 500ug/50ug Powder for inhalation Dry powder Inhaler (338158)

Product Name
SALFLUMIX EASYHALER 500/50 fluticasone propionate/salmeterol (as xinafoate) 500ug/50ug Powder for inhalation Dry powder Inhaler
Approval Date
Oct 28, 2022
TGA

BUFOMIX EASYHALER 400/12 budesonide/formoterol (eformoterol) fumarate dihydrate 320 ug/9 ug per inhalation powder for inhalation dry powder inhaler (338160)

Product Name
BUFOMIX EASYHALER 400/12 budesonide/formoterol (eformoterol) fumarate dihydrate 320 ug/9 ug per inhalation powder for inhalation dry powder inhaler
Approval Date
Oct 28, 2022
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.